AR111770A1 - Vacuna para enfermedad respiratoria bovina - Google Patents

Vacuna para enfermedad respiratoria bovina

Info

Publication number
AR111770A1
AR111770A1 ARP180101021A ARP180101021A AR111770A1 AR 111770 A1 AR111770 A1 AR 111770A1 AR P180101021 A ARP180101021 A AR P180101021A AR P180101021 A ARP180101021 A AR P180101021A AR 111770 A1 AR111770 A1 AR 111770A1
Authority
AR
Argentina
Prior art keywords
bovine respiratory
respiratory disease
vaccine
vaccines
bovine
Prior art date
Application number
ARP180101021A
Other languages
English (en)
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of AR111770A1 publication Critical patent/AR111770A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacunas para tratar la enfermedad respiratoria bovina. Tales vacunas contienen una combinación de virus de gripe D bovina y antígenos de Mannheimia haemolytica. Una infección respiratoria superior con un IDV lleva a un aumento de potencial para la patología de M. haemolytica en los pulmones. Las vacunas pueden contener antígenos adicionales de otros patógenos respiratorios bovinos.
ARP180101021A 2017-05-05 2018-04-20 Vacuna para enfermedad respiratoria bovina AR111770A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762502004P 2017-05-05 2017-05-05

Publications (1)

Publication Number Publication Date
AR111770A1 true AR111770A1 (es) 2019-08-21

Family

ID=62165675

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101021A AR111770A1 (es) 2017-05-05 2018-04-20 Vacuna para enfermedad respiratoria bovina

Country Status (12)

Country Link
US (1) US11439701B2 (es)
EP (1) EP3618858A1 (es)
JP (2) JP7341120B2 (es)
CN (1) CN110545839A (es)
AR (1) AR111770A1 (es)
AU (1) AU2018262481B2 (es)
BR (1) BR112019020635A2 (es)
CA (1) CA3060122A1 (es)
MX (1) MX2019013154A (es)
NZ (1) NZ757651A (es)
RU (1) RU2762938C2 (es)
WO (1) WO2018204178A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220005606A1 (en) * 2018-11-14 2022-01-06 The Regents Of The University Of California Methods of Determining the risk of Bovine Respiratory Disease in Pre-weaned Dairy Calves
CN113552191B (zh) * 2021-07-28 2023-11-21 江苏师范大学 基于多层dna放大回路检测甲基化dna的比例型电化学传感器的构建方法
CN116785420B (zh) * 2023-08-21 2023-11-14 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种牛病毒性腹泻病毒的mRNA疫苗及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3312272T3 (da) 2004-10-08 2019-12-02 Us Gov Health & Human Services Modulering af replikationstilpasning ved brug a mindre optrædende synonyme kodoner
BRPI0809600B1 (pt) 2007-03-30 2023-01-24 The Research Foundation Of State University Of New York Vírus atenuado útil para vacinas
RU2403061C1 (ru) * 2009-06-29 2010-11-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина инактивированная комбинированная против инфекционного ринотрахеита, парагриппа-3, респираторно-синцитиальной болезни, вирусной диареи и пастереллеза крупного рогатого скота
TWI396547B (zh) * 2009-09-02 2013-05-21 Univ Nat Pingtung Sci & Tech 溶血性曼哈米亞桿菌疫苗
US9278999B2 (en) 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
MX2015000789A (es) 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
DK2969005T3 (da) 2013-03-15 2020-01-20 The Resaerch Foundation For The State Univ Of New York Attenuerede influenzavira og -vacciner
WO2017087492A1 (en) 2015-11-16 2017-05-26 Kansas State University Research Foundation Influenza virus vaccine and vaccine platform

Also Published As

Publication number Publication date
RU2019132984A3 (es) 2021-06-07
RU2762938C2 (ru) 2021-12-24
US20210338799A1 (en) 2021-11-04
JP7341120B2 (ja) 2023-09-08
CN110545839A (zh) 2019-12-06
WO2018204178A1 (en) 2018-11-08
RU2019132984A (ru) 2021-06-07
NZ757651A (en) 2022-07-01
AU2018262481B2 (en) 2021-07-29
BR112019020635A2 (pt) 2020-04-22
MX2019013154A (es) 2020-02-05
JP2020516691A (ja) 2020-06-11
EP3618858A1 (en) 2020-03-11
AU2018262481A1 (en) 2019-10-17
JP2022070898A (ja) 2022-05-13
US11439701B2 (en) 2022-09-13
CA3060122A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
CL2020000912A1 (es) Compuestos químicos
MX2018007627A (es) Vacuna contra el virus del zika.
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
CO2021004456A2 (es) Vacunas neumocócicas multivalentes
TW201613556A (en) Swine virus vaccines that are liquid stable
AR111770A1 (es) Vacuna para enfermedad respiratoria bovina
CL2016002794A1 (es) Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico
MX2022002106A (es) Formulaciones de vacuna de vial unico.
MX355078B (es) Vacuna de subunidades anti-mycoplasma spp.
PT3534939T (pt) Vacina contra parvovírus porcino e vírus da síndrome reprodutiva e respiratória porcina e métodos da sua produção
EA201792512A1 (ru) Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
DK3244920T3 (da) Mund- og klovsyge-vaccine
EA201691638A1 (ru) Новые способы индуцирования иммунного ответа
CR20160495A (es) Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas
ES2544153B1 (es) Uso de un hidrolizado de caseína como agente antiviral
EA201700114A1 (ru) Капсаициноиды и их применение в качестве лекарственных средств
EA201790991A1 (ru) Способ лечения с использованием пегилированного интерферона
DK2941269T3 (da) Terapeutiske vacciner til behandling af herpes simplex-virus type 2-infektioner
EA201890181A1 (ru) Применение декаметоксина как фармацевтически активного вещества для лечения заболеваний желудочно-кишечного тракта и кишечных инфекций перорально
SG11202011004RA (en) Hepatitis b vaccine transnasal administration system
EA201892739A1 (ru) Способы лечения болезни альцгеймера
PL411372A1 (pl) Bakteriofagi nadające się do wytwarzania szczepionek oraz sposób ich otrzymywania
UA131944U (uk) Лікарський препарат для профілактики і лікування простатиту
EA201992167A1 (ru) Вакцина